Borsatti E - Search Results

1

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.

Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, Borsatti E, Drigo A, Trovò MG. Cimitan M, et al. Among authors: borsatti e. Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1387-98. doi: 10.1007/s00259-006-0150-2. Epub 2006 Jul 25. Eur J Nucl Med Mol Imaging. 2006. PMID: 16865395

2

Usefulness of immunoscintigraphy in the follow-up of surgically treated gastrointestinal carcinomas using 111In-labelled anti-CEA monoclonal antibodies.

Cimitan M, Boz G, Spaziante R, Sorce P, De Paoli A, Baldoncini A, Borsatti E, Trovò MG, Zecchin R. Cimitan M, et al. Among authors: borsatti e. Clin Oncol (R Coll Radiol). 1992 Nov;4(6):368-72. doi: 10.1016/s0936-6555(05)81129-x. Clin Oncol (R Coll Radiol). 1992. PMID: 1463689

3

The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography.

Cimitan M, Volpe R, Candiani E, Gusso G, Ruffo R, Borsatti E, Massarut S, Rossi C, Morassut S, Carbone A. Cimitan M, et al. Among authors: borsatti e. Eur J Nucl Med. 1995 Oct;22(10):1110-7. doi: 10.1007/BF00800591. Eur J Nucl Med. 1995. PMID: 8542893

4

Somatostatin receptor scintigraphy versus chromogranin A assay in the management of patients with neuroendocrine tumors of different types: clinical role.

Cimitan M, Buonadonna A, Cannizzaro R, Canzonieri V, Borsatti E, Ruffo R, De Apollonia L. Cimitan M, et al. Among authors: borsatti e. Ann Oncol. 2003 Jul;14(7):1135-41. doi: 10.1093/annonc/mdg279. Ann Oncol. 2003. PMID: 12853358 Free article. Clinical Trial.

5

Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.

Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M. Comoretto M, et al. Among authors: borsatti e. Radiology. 2008 Oct;249(1):203-11. doi: 10.1148/radiol.2491071753. Epub 2008 Aug 18. Radiology. 2008. PMID: 18710963

6

Pitfalls in the dermoscopic diagnosis of amelanotic melanoma.

Pizzichetta MA, Canzonieri V, Massarut S, Baresic T, Borsatti E, Menzies SW. Pizzichetta MA, et al. Among authors: borsatti e. J Am Acad Dermatol. 2010 May;62(5):893-4. doi: 10.1016/j.jaad.2009.09.036. J Am Acad Dermatol. 2010. PMID: 20398822 No abstract available.

7

Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.

Gobitti C, Borsatti E, Arcicasa M, Roncadin M, Franchin G, Minatel E, Skrap M, Zanotti B, Tuniz F, Cimitan M, Capra E, Drigo A, Trovò MG. Gobitti C, et al. Among authors: borsatti e. Tumori. 2011 Sep-Oct;97(5):614-9. doi: 10.1177/030089161109700513. Tumori. 2011. PMID: 22158493 Clinical Trial.

8

Revisiting the clinical value of 18F-FDG PET/CT in detection of recurrent epithelial ovarian carcinomas: correlation with histology, serum CA-125 assay, and conventional radiological modalities.

Antunovic L, Cimitan M, Borsatti E, Baresic T, Sorio R, Giorda G, Steffan A, Balestreri L, Tatta R, Pepe G, Rubello D, Cecchin D, Canzonieri V. Antunovic L, et al. Among authors: borsatti e. Clin Nucl Med. 2012 Aug;37(8):e184-8. doi: 10.1097/RLU.0b013e31825b2583. Clin Nucl Med. 2012. PMID: 22785525

9

Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease.

Cimitan M, Hodolič M, Maffione AM, Borsatti E, Urso C, Colletti PM, Rubello D. Cimitan M, et al. Among authors: borsatti e. Clin Nucl Med. 2013 Sep;38(9):752-4. doi: 10.1097/RLU.0b013e31829af8a6. Clin Nucl Med. 2013. PMID: 23856823

10

Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patients.

Berretta M, Aprile G, Nasti G, Urbani M, Bearz A, Lutrino S, Foltran L, Ferrari L, Talamini R, Fiorica F, Lleshi A, Canzonieri V, Lestuzzi C, Borsatti E, Fisichella R, Tirelli U. Berretta M, et al. Among authors: borsatti e. Anticancer Agents Med Chem. 2013 Nov;13(9):1344-53. doi: 10.2174/18715206113136660347. Anticancer Agents Med Chem. 2013. PMID: 24102280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters